市場調査レポート

商品コード

組み換えタンパク質の世界市場 2025-2029

Global Recombinant Proteins Market 2025-2029

出版日: 2025年04月04日
発行: TechNavio
ページ情報: 英文 203 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 360,150円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 576,240円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

組み換えタンパク質市場は2024-2029年に8億9,910万米ドル、予測期間中のCAGRは10.7％で成長すると予測されます。

当レポートでは、組み換えタンパク質市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。慢性疾患の増加、生物製剤やバイオシミラーへの傾斜の高まり、組み換えタンパク質の生産における技術進歩などが市場を牽引しています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比2025年	9.8%
CAGR	10.7%
増分額	8億9,910万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間の組み換えタンパク質市場の成長を促進する主な要因の一つとして、企業による共同研究や戦略的提携の増加を挙げています。また、研究開発への支出の増加や新興経済諸国からのビジネスチャンスの拡大は、市場の大きな需要につながると考えられます。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
アジア：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
韓国：市場規模と予測 2024-2029
市場機会：地域情勢別

第12章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第13章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第14章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Abcam plc
Amgen Inc.
Aviva Systems Biology Corp.
Bio Rad Laboratories Inc.
BPS Bioscience Inc.
Enzo Biochem Inc.
GenScript Biotech Corp.
Merck KGaA
Novartis AG
Novo Nordisk AS
Prospec Tany Technogene Ltd.
Proteintech Group Inc.
Sanofi SA
Sino Biological Inc.
Thermo Fisher Scientific Inc.

第15章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Recombinant Proteins Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Application - Market share 2024-2029 (%)
Exhibits37: Data Table on Application - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Application
Exhibits39: Data Table on Comparison by Application
Exhibits40: Chart on Biotechnology research - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Biotechnology research - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Biotechnology research - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Biotechnology research - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Drug discovery and development - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Drug discovery and development - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Drug discovery and development - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Drug discovery and development - Year-over-year growth 2024-2029 (%)
Exhibits48: Chart on Biopharmaceutical production - Market size and forecast 2024-2029 ($ million)
Exhibits49: Data Table on Biopharmaceutical production - Market size and forecast 2024-2029 ($ million)
Exhibits50: Chart on Biopharmaceutical production - Year-over-year growth 2024-2029 (%)
Exhibits51: Data Table on Biopharmaceutical production - Year-over-year growth 2024-2029 (%)
Exhibits52: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits53: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits54: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits55: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits56: Market opportunity by Application ($ million)
Exhibits57: Data Table on Market opportunity by Application ($ million)
Exhibits58: Chart on End-user - Market share 2024-2029 (%)
Exhibits59: Data Table on End-user - Market share 2024-2029 (%)
Exhibits60: Chart on Comparison by End-user
Exhibits61: Data Table on Comparison by End-user
Exhibits62: Chart on Pharma and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Pharma and biotechnology companies - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Pharma and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Pharma and biotechnology companies - Year-over-year growth 2024-2029 (%)
Exhibits66: Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits67: Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
Exhibits68: Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits69: Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
Exhibits70: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits71: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits72: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits73: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits74: Market opportunity by End-user ($ million)
Exhibits75: Data Table on Market opportunity by End-user ($ million)
Exhibits76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits77: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits78: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits79: Chart on Geographic comparison
Exhibits80: Data Table on Geographic comparison
Exhibits81: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits137: Market opportunity By Geographical Landscape ($ million)
Exhibits138: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits139: Impact of drivers and challenges in 2024 and 2029
Exhibits140: Overview on criticality of inputs and factors of differentiation
Exhibits141: Overview on factors of disruption
Exhibits142: Impact of key risks on business
Exhibits143: Companies covered
Exhibits144: Company ranking index
Exhibits145: Matrix on companies position and classification
Exhibits146: Abcam plc - Overview
Exhibits147: Abcam plc - Product / Service
Exhibits148: Abcam plc - Key news
Exhibits149: Abcam plc - Key offerings
Exhibits150: SWOT
Exhibits151: Amgen Inc. - Overview
Exhibits152: Amgen Inc. - Product / Service
Exhibits153: Amgen Inc. - Key news
Exhibits154: Amgen Inc. - Key offerings
Exhibits155: SWOT
Exhibits156: Aviva Systems Biology Corp. - Overview
Exhibits157: Aviva Systems Biology Corp. - Product / Service
Exhibits158: Aviva Systems Biology Corp. - Key offerings
Exhibits159: SWOT
Exhibits160: Bio Rad Laboratories Inc. - Overview
Exhibits161: Bio Rad Laboratories Inc. - Business segments
Exhibits162: Bio Rad Laboratories Inc. - Key news
Exhibits163: Bio Rad Laboratories Inc. - Key offerings
Exhibits164: Bio Rad Laboratories Inc. - Segment focus
Exhibits165: SWOT
Exhibits166: BPS Bioscience Inc. - Overview
Exhibits167: BPS Bioscience Inc. - Product / Service
Exhibits168: BPS Bioscience Inc. - Key offerings
Exhibits169: SWOT
Exhibits170: Enzo Biochem Inc. - Overview
Exhibits171: Enzo Biochem Inc. - Product / Service
Exhibits172: Enzo Biochem Inc. - Key news
Exhibits173: Enzo Biochem Inc. - Key offerings
Exhibits174: SWOT
Exhibits175: GenScript Biotech Corp. - Overview
Exhibits176: GenScript Biotech Corp. - Business segments
Exhibits177: GenScript Biotech Corp. - Key news
Exhibits178: GenScript Biotech Corp. - Key offerings
Exhibits179: GenScript Biotech Corp. - Segment focus
Exhibits180: SWOT
Exhibits181: Merck KGaA - Overview
Exhibits182: Merck KGaA - Business segments
Exhibits183: Merck KGaA - Key news
Exhibits184: Merck KGaA - Key offerings
Exhibits185: Merck KGaA - Segment focus
Exhibits186: SWOT
Exhibits187: Novartis AG - Overview
Exhibits188: Novartis AG - Business segments
Exhibits189: Novartis AG - Key news
Exhibits190: Novartis AG - Key offerings
Exhibits191: Novartis AG - Segment focus
Exhibits192: SWOT
Exhibits193: Novo Nordisk AS - Overview
Exhibits194: Novo Nordisk AS - Business segments
Exhibits195: Novo Nordisk AS - Key offerings
Exhibits196: Novo Nordisk AS - Segment focus
Exhibits197: SWOT
Exhibits198: Prospec Tany Technogene Ltd. - Overview
Exhibits199: Prospec Tany Technogene Ltd. - Product / Service
Exhibits200: Prospec Tany Technogene Ltd. - Key offerings
Exhibits201: SWOT
Exhibits202: Proteintech Group Inc. - Overview
Exhibits203: Proteintech Group Inc. - Product / Service
Exhibits204: Proteintech Group Inc. - Key offerings
Exhibits205: SWOT
Exhibits206: Sanofi SA - Overview
Exhibits207: Sanofi SA - Business segments
Exhibits208: Sanofi SA - Key news
Exhibits209: Sanofi SA - Key offerings
Exhibits210: Sanofi SA - Segment focus
Exhibits211: SWOT
Exhibits212: Sino Biological Inc. - Overview
Exhibits213: Sino Biological Inc. - Product / Service
Exhibits214: Sino Biological Inc. - Key offerings
Exhibits215: SWOT
Exhibits216: Thermo Fisher Scientific Inc. - Overview
Exhibits217: Thermo Fisher Scientific Inc. - Business segments
Exhibits218: Thermo Fisher Scientific Inc. - Key news
Exhibits219: Thermo Fisher Scientific Inc. - Key offerings
Exhibits220: Thermo Fisher Scientific Inc. - Segment focus
Exhibits221: SWOT
Exhibits222: Inclusions checklist
Exhibits223: Exclusions checklist
Exhibits224: Currency conversion rates for US$
Exhibits225: Research methodology
Exhibits226: Information sources
Exhibits227: Data validation
Exhibits228: Validation techniques employed for market sizing
Exhibits229: Data synthesis
Exhibits230: 360 degree market analysis
Exhibits231: List of abbreviations

Product Code: IRTNTR74151

The recombinant proteins market is forecasted to grow by USD 899.1 mn during 2024-2029, accelerating at a CAGR of 10.7% during the forecast period. The report on the recombinant proteins market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in chronic diseases, rising inclination toward biologics and biosimilars, and technological advancements in production of recombinant proteins.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	9.8%
CAGR	10.7%
Incremental Value	$899.1 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's recombinant proteins market is segmented as below:

By Application

Biotechnology research
Drug discovery and development
Biopharmaceutical production
Others

By End-user

Pharma and biotechnology companies
Academic and research institutes
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in collaborations and strategic alliances by companies as one of the prime reasons driving the recombinant proteins market growth during the next few years. Also, increased expenditure on research and development and growing opportunities from emerging economies will lead to sizable demand in the market.

The report on the recombinant proteins market covers the following areas:

Recombinant Proteins Market sizing
Recombinant Proteins Market forecast
Recombinant Proteins Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading recombinant proteins market vendors that include Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Rad Laboratories Inc., Bio Techne Corp., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., Grifols SA, Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the recombinant proteins market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Recombinant Proteins Market 2019 - 2023
- Historic Market Size - Data Table on Global Recombinant Proteins Market 2019 - 2023 ($ million)
5.2 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Recombinant Proteins Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
8.3 Biotechnology research - Market size and forecast 2024-2029
- Chart on Biotechnology research - Market size and forecast 2024-2029 ($ million)
- Data Table on Biotechnology research - Market size and forecast 2024-2029 ($ million)
- Chart on Biotechnology research - Year-over-year growth 2024-2029 (%)
- Data Table on Biotechnology research - Year-over-year growth 2024-2029 (%)
8.4 Drug discovery and development - Market size and forecast 2024-2029
- Chart on Drug discovery and development - Market size and forecast 2024-2029 ($ million)
- Data Table on Drug discovery and development - Market size and forecast 2024-2029 ($ million)
- Chart on Drug discovery and development - Year-over-year growth 2024-2029 (%)
- Data Table on Drug discovery and development - Year-over-year growth 2024-2029 (%)
8.5 Biopharmaceutical production - Market size and forecast 2024-2029
- Chart on Biopharmaceutical production - Market size and forecast 2024-2029 ($ million)
- Data Table on Biopharmaceutical production - Market size and forecast 2024-2029 ($ million)
- Chart on Biopharmaceutical production - Year-over-year growth 2024-2029 (%)
- Data Table on Biopharmaceutical production - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by End-user

9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
9.3 Pharma and biotechnology companies - Market size and forecast 2024-2029
- Chart on Pharma and biotechnology companies - Market size and forecast 2024-2029 ($ million)
- Data Table on Pharma and biotechnology companies - Market size and forecast 2024-2029 ($ million)
- Chart on Pharma and biotechnology companies - Year-over-year growth 2024-2029 (%)
- Data Table on Pharma and biotechnology companies - Year-over-year growth 2024-2029 (%)
9.4 Academic and research institutes - Market size and forecast 2024-2029
- Chart on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
- Data Table on Academic and research institutes - Market size and forecast 2024-2029 ($ million)
- Chart on Academic and research institutes - Year-over-year growth 2024-2029 (%)
- Data Table on Academic and research institutes - Year-over-year growth 2024-2029 (%)
9.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.10 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.11 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
11.13 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.14 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.15 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Abcam plc
- Abcam plc - Overview
- Abcam plc - Product / Service
- Abcam plc - Key news
- Abcam plc - Key offerings
- SWOT
14.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
14.6 Aviva Systems Biology Corp.
- Aviva Systems Biology Corp. - Overview
- Aviva Systems Biology Corp. - Product / Service
- Aviva Systems Biology Corp. - Key offerings
- SWOT
14.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
14.8 BPS Bioscience Inc.
- BPS Bioscience Inc. - Overview
- BPS Bioscience Inc. - Product / Service
- BPS Bioscience Inc. - Key offerings
- SWOT
14.9 Enzo Biochem Inc.
- Enzo Biochem Inc. - Overview
- Enzo Biochem Inc. - Product / Service
- Enzo Biochem Inc. - Key news
- Enzo Biochem Inc. - Key offerings
- SWOT
14.10 GenScript Biotech Corp.
- GenScript Biotech Corp. - Overview
- GenScript Biotech Corp. - Business segments
- GenScript Biotech Corp. - Key news
- GenScript Biotech Corp. - Key offerings
- GenScript Biotech Corp. - Segment focus
- SWOT
14.11 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
14.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
14.13 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Business segments
- Novo Nordisk AS - Key offerings
- Novo Nordisk AS - Segment focus
- SWOT
14.14 Prospec Tany Technogene Ltd.
- Prospec Tany Technogene Ltd. - Overview
- Prospec Tany Technogene Ltd. - Product / Service
- Prospec Tany Technogene Ltd. - Key offerings
- SWOT
14.15 Proteintech Group Inc.
- Proteintech Group Inc. - Overview
- Proteintech Group Inc. - Product / Service
- Proteintech Group Inc. - Key offerings
- SWOT
14.16 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
14.17 Sino Biological Inc.
- Sino Biological Inc. - Overview
- Sino Biological Inc. - Product / Service
- Sino Biological Inc. - Key offerings
- SWOT
14.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

組み換えタンパク質の世界市場 2025-2029

Global Recombinant Proteins Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：用途別

第9章市場セグメンテーション：エンドユーザー別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Application

9 Market Segmentation by End-user

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

組み換えタンパク質の世界市場 2025-2029

Global Recombinant Proteins Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：用途別

第9章 市場セグメンテーション：エンドユーザー別

第10章 顧客情勢

第11章 地域別情勢

第12章 促進要因・課題・機会・抑制要因

第13章 競合情勢

第14章 競合分析

第15章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Application

9 Market Segmentation by End-user

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：用途別

第9章市場セグメンテーション：エンドユーザー別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録